We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
75 hedge funds and large institutions have $383M invested in Alder Biopharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
600% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 3
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
135% more capital invested
Capital invested by funds: $163M → $383M (+$220M)
32% more funds holding
Funds holding: 57 → 75 (+18)
12% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 25
Holders
75
Holders Change
+18
Holders Change %
+31.58%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
21
Increased
22
Reduced
25
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.2M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.08M |
| 3 |
Goldman Sachs
New York
|
+$3.81M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$1.79M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.58M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$12.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.17M |
| 3 |
PC
PointState Capital
New York
|
-$3.59M |
| 4 |
CCM
Cadian Capital Management
New York
|
-$1.52M |
| 5 |
Jennison Associates
New York
|
-$1.4M |
